NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional)
ID: 337270Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/337270

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-22-362.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a Funding Opportunity Announcement (FOA) for the renewal and competing revision of U01 research project cooperative agreements focused on aging research. This initiative aims to support projects that address various aspects of the aging process and related health issues, including Alzheimer's disease, and is open to a diverse range of eligible applicants, including higher education institutions, non-profits, and for-profit organizations with active awards. The application process is conducted electronically through Grants.gov, adhering to specific NIH guidelines, with key evaluation criteria including the significance of the proposed research, investigator qualifications, and innovation. Interested applicants should note that the submission deadline is October 1, 2024, and can find further details and contact information at the provided NIH link: http://grants.nih.gov/grants/guide/pa-files/PAR-22-362.html.

    Point(s) of Contact
    OERWebmaster03@od.nih.gov
    Files
    Title
    Posted
    PAR-22-362-Full-Announcement.html
    PAR-22-362.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has issued a Funding Opportunity Announcement (FOA) for the renewal and competing revision of U01 research project cooperative agreements in aging research. The funding is aimed at facilitating projects focused on various aspects of the aging process and associated health issues, including Alzheimer's disease. Eligible applicants include higher education institutions, non-profits, and for-profit organizations, provided they hold active awards at the time of submission. The application process is conducted electronically via platforms like Grants.gov and requires adherence to specific NIH guidelines. Key dates include submission deadlines and review cycles extending into 2023 and beyond. Important factors considered in the review process include the impact and significance of the proposed research, investigator qualifications, innovation, methodology, and potential challenges. Applications are subject to rigorous evaluation to ensure compliance with NIH Grant policies. This FOA emphasizes collaboration and considerable federal oversight, highlighting the importance of aging research in addressing the challenges facing older Americans.
    Similar Opportunities
    NIA Program Project Applications (P01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIA Program Project Grants (P01 Clinical Trial Optional), aimed at advancing research in aging-related scientific areas. Applicants must propose at least three interrelated research projects centered around a common theme, along with an administrative core to manage the initiative, addressing topics such as genetics, biology, and Alzheimer’s disease. This funding opportunity is crucial for fostering collaborative research efforts among established scientists and early-career researchers, ultimately contributing to the understanding and improvement of public health concerning aging. Interested organizations must submit their applications by September 7, 2025, and can find additional details and requirements at the provided NIH link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity (PAR-23-054) aimed at advancing interdisciplinary research in aging through the development and utilization of novel research infrastructures. This initiative encourages applicants to propose projects that enhance the understanding of aging by fostering collaborations across various scientific disciplines, with a focus on producing tangible scientific results such as new knowledge or tools. The funding is particularly relevant for addressing significant aging-related questions and improving the management of age-related health issues. Eligible applicants include higher education institutions, nonprofits, and government entities, with a funding ceiling of $500,000 and a close date for applications set for December 2, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-054.html.
    Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Multidisciplinary Studies of HIV/AIDS and Aging," inviting applications for research that explores the intersection of HIV and aging. The primary objectives of this grant are to enhance understanding of the biological, clinical, and socio-behavioral aspects of aging in individuals living with HIV, as well as to improve strategies for testing, preventing, and treating HIV and managing related health complications. This funding opportunity is significant for advancing health interventions for older adults affected by HIV, with eligible applicants including a wide range of institutions such as higher education entities, community organizations, and tribal governments. Interested parties should note that the application deadline is May 7, 2027, and can find further details and guidance by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-091.html.
    Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)" aimed at advancing the science of aging through innovative research infrastructure. This initiative invites applications from a diverse range of eligible institutions to develop sustainable frameworks that address critical interdisciplinary questions in aging, with a focus on areas such as machine learning applications, health disparities, and behavioral aspects of aging. The funding mechanism provides up to five years of support, including two years for initial developmental activities and up to three years for expanded activities, with an award ceiling of $500,000. Interested applicants can find more information and application guidelines at the NIH website, and must submit their proposals by December 2, 2025, to be considered for this discretionary grant opportunity.
    Centers on the Demography and Economics of Aging and Alzheimers Disease and Alzheimers Disease-Related Dementias Coordinating Center (U24 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the establishment of a Coordinating Center focused on the Demography and Economics of Aging, particularly concerning Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD). This initiative aims to create a collaborative hub that enhances scientific communication and research among various Centers dedicated to aging research, with a funding commitment of approximately $1,320,000 for FY 2025, targeting a single award with a maximum project budget of $800,000 for the first year. The program emphasizes the importance of interdisciplinary research and aims to address health disparities while fostering mentorship and training opportunities across diverse institutional backgrounds. Interested applicants must submit their proposals by November 1, 2024, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Alzheimer's Drug-Development Program (Funding Opportunity Number: PAR-24-223), aimed at supporting the preclinical and early-stage clinical development of innovative drug candidates for Alzheimer's disease (AD). The program focuses on funding activities such as medicinal chemistry, pharmacokinetics, and Investigational New Drug (IND)-enabling studies, with the goal of advancing viable therapies to address the significant public health challenge posed by AD. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofits, and tribal organizations, with awards reaching up to $1.5 million over a period of up to five years for early-stage projects. Interested parties should submit their applications by November 5, 2027, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Healthcare for Older Adults from Populations that Experience Health Disparities" under the R01 Clinical Trial Optional grant program. This initiative aims to enhance the science and implementation of healthcare research focused on older adults from populations facing health disparities, specifically targeting improvements in screening, diagnostic, and clinical care guidelines, as well as fostering shared decision-making between clinicians and patients. The research is particularly significant for addressing the unique health challenges encountered by older adults from racial and ethnic minorities and underserved communities, emphasizing innovative care solutions that consider social determinants of health. Interested applicants can find more information and apply through the NIH Grants website, with the application opening on January 5, 2025, and a close date set for January 7, 2028. For inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.
    Centers on the Demography and Economics of Aging, Including Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (D and E Centers) (P30 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Centers on the Demography and Economics of Aging, Including Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD)" program, aimed at developing or renewing Research and Development Centers focused on population-based aging research. The program's objectives include seeding innovative aging research, addressing health disparities, and engaging scholars across various disciplines, with a particular emphasis on cognitive aging and caregiving. This initiative is crucial for advancing understanding in the field of aging and health disparities, with an anticipated total funding of approximately $9 million for general aging projects and $2.25 million specifically for AD/ADRD projects. Applications are due by November 1, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Notice of Intent to Publish a Funding Opportunity Announcement for Facilitating Preclinical and Early Phase Human Studies for New Therapeutics (UG3/UH3 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for facilitating preclinical and early phase human studies for new therapeutics, specifically targeting aging-related conditions. This initiative aims to advance T1 translational aging research, focusing on therapeutics that progress from preclinical stages to first-in-human trials, addressing conditions such as sarcopenia and heart failure with preserved ejection fraction (HFpEF). The funding opportunity, categorized under health-related activities, will utilize the UG3/UH3 Cooperative Agreement mechanism, with an estimated total program funding of $2.5 million. Interested applicants should prepare to submit their applications by fall 2024, with the NOFO expected to be published in summer 2024 and awards anticipated by July 2025.
    Deciphering the Impact of RNA Modifications on Brain Aging and AD/ADRD (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), has announced a funding opportunity titled "Deciphering the Impact of RNA Modifications on Brain Aging and AD/ADRD (R01 Clinical Trial Not Allowed)." This grant aims to support innovative research that elucidates the molecular mechanisms and functional implications of RNA modifications in relation to brain aging and Alzheimer's disease (AD) and related dementias (ADRD), including Lewy body dementia and frontotemporal dementia. The initiative is crucial for advancing understanding in this field, with the ultimate goal of identifying biomarkers and therapeutic targets that could lead to improved health outcomes for affected populations. Eligible applicants can request up to $500,000 in direct costs per year for projects lasting a maximum of five years, with a total funding allocation of $4 million for fiscal year 2025. Applications are due by November 1, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.